Some studies have reported a higher incidence of brain metastasis among patients with epidermal growth factor receptor (EGFR)- or anaplastic lymphoma kinase (ALK)-mutant NSCLC [1, 11, 12]. This evidence concerns the gene ALK and non-small cell lung carcinoma.